Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by monty613on Jan 13, 2022 3:38pm
196 Views
Post# 34314260

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Here it goes

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Here it goes
bandit69 wrote:
 But they are real costs to a business. 


the thing is WELL's depreciation and amortization is largely comprised of the amortization of CRH's contracts / JVs which are not real costs to the business.

on an accounting basis they have lost money in 2021 - they incurred one-time expenses to buy CRH and MyHealth among other companies. you're focused on the balance sheet, when it's the income statement and cashflow statement you should be focusing on.

they bought cashflows. if they stop acquiring, they have a portfolio of healthcare companies which generate stable and recurring profits. the leverage used was reasonable and much of it was from senior debt indicating the banks are comfortable with the ability of the companies to debt service.

hate EBITDA all you want, but for a growth company like this it's the best metric to focus on because of all the noise due to the acquisitions. i'm aware it can be played with but the company has provide detailed disclosures of the add-backs and I'm comfortable with them.

cheers.

<< Previous
Bullboard Posts
Next >>